XtalPi completed the acquisition of Liverpool ChiroChem.

XtalPi, a life sciences and new materials R&D platform powered by quantum physics, completed the acquisition of Liverpool ChiroChem, an automated chiral chemistry technologies company. Financial terms were not disclosed. "The partnership of LCC and XtalPi creates a platform technology that has the potential to become the most powerful data engine in the world for chemical space exploration, fuelling AI/ML models with large volumes of high-quality data in a fully integrated wet-dry lab cycle. I am delighted to stay on in my position and guide the collaboration between these two excellent teams that already share a common vision of developing tools that enable scientists to deliver impactful innovation," Paul Colbon, LCC CEO.